TARO PHARMACEUTICAL INDUSTRIES LTD reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Haifa Bay, Israel
SEC filing record 1 source field available
Fiscal year end
31 March
TARO PHARMACEUTICAL INDUSTRIES LTD has filed 610 SEC EDGAR filings since 12 Feb 1997

SEC filing history

Showing 26-50 of 213 matching filings.

Per page
25
Current page
2
6-K File 001-35463

6-K

Filing date
01 Dec 2021
Reporting date
01 Dec 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-35463

6-K

Filing date
05 Nov 2021
Reporting date
05 Nov 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-35463

6-K

Filing date
04 Nov 2021
Reporting date
04 Nov 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-35463

6-K

Filing date
28 Oct 2021
Reporting date
30 Sep 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-35463

6-K

Filing date
28 Jul 2021
Reporting date
30 Jun 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-35463

6-K

Filing date
15 Jul 2021
Reporting date
14 Jul 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-35463

6-K

Filing date
20 May 2021
Reporting date
31 Mar 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-35463

6-K

Filing date
28 Jan 2021
Reporting date
31 Dec 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-35463

6-K

Filing date
21 Dec 2020
Reporting date
14 Dec 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-35463

6-K

Filing date
04 Nov 2020
Reporting date
04 Nov 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-35463

6-K

Filing date
28 Oct 2020
Reporting date
30 Sep 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-35463

6-K

Filing date
29 Jul 2020
Reporting date
30 Jun 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-35463

6-K - DOJ

Filing date
23 Jul 2020
Reporting date
23 Jul 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-35463

6-K

Filing date
20 May 2020
Reporting date
31 Mar 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-35463

6-K

Filing date
06 Apr 2020
Reporting date
06 Apr 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-35463

6-K

Filing date
21 Feb 2020
Reporting date
20 Feb 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-35463

6-K

Filing date
07 Feb 2020
Reporting date
06 Feb 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-35463

6-K

Filing date
04 Feb 2020
Reporting date
03 Feb 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-35463

6-K

Filing date
10 Jan 2020
Reporting date
10 Jan 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-35463

6-K - EGM PROXY STATEMENT & PROXY CARD

Filing date
30 Dec 2019
Reporting date
30 Dec 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-35463

6-K - EGM

Filing date
23 Dec 2019
Reporting date
23 Dec 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-35463

6-K

Filing date
23 Dec 2019
Reporting date
23 Dec 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-35463

6-K

Filing date
17 Dec 2019
Reporting date
17 Dec 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-35463

TARO PHARMACEUTICAL INDUSTRIES LTD. 6-K

Filing date
06 Dec 2019
Reporting date
06 Dec 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-35463

TARO-2019-11-14-6-K

Filing date
15 Nov 2019
Reporting date
15 Nov 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .